147 results
Page 2 of 8
8-K
69adk3h1xxsr0kqj0
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
gvd 4nhouk
14 Jun 23
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
8:30am
DEFA14A
gj4ay
18 May 23
Additional proxy soliciting materials
8:32am
8-K
cmltk1sare7o1 vepo
18 May 23
NanoVibronix Issues Letter to Shareholders
8:30am
DEFA14A
n43n5zuvsp5vd13sxat
1 May 23
Additional proxy soliciting materials
4:47pm
8-K
gaht ytt21
19 Apr 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:30pm
8-K
EX-10.1
skks 4pszdbqlp9
1 Dec 22
NanoVibronix Announces $2.4 Million Registered
6:06am
424B5
q3xe7
30 Nov 22
Prospectus supplement for primary offering
5:29pm
8-K
l5l9e5tm8jloj1jpth
16 Nov 22
NanoVibronix Announces Interim Results of Clinical Study for UroShield
8:30am
DEFA14A
1rdzbybwgdc5nhoq78
15 Nov 22
Additional proxy soliciting materials
9:26am
DEFA14A
1w5g9
31 Oct 22
Additional proxy soliciting materials
8:20am
8-K
bmkep
23 Sep 22
NanoVibronix UroShield Approved for Sale through NHS Internal
8:30am
DEFA14A
psc6n0ny69gr7kgt
15 Sep 22
Additional proxy soliciting materials
9:40am